Back

Effects of combined uptitration of ACE-inhibitors and beta-blockers in heart failure with reduced ejection fraction

27 May 2019 (08:48 - 08:54)
Organised by:
Congress Presentation Part of: Rapid Fire 4 - Chronic heart failure - Pharmacology Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Wouter Ouwerkerk

Academic Medical Centre, Amsterdam (Netherlands (The))

14 More presentations in this session

Presentation thumbnail
Heart failure outcomes in patients with diabetes with and without atrial fibrillation - data from the EMPA-REG OUTCOME study
Professor M. Boehm (Homburg, DE)
Abstract Slides Video
Presentation thumbnail
Eligibility for EMPEROR trials in a real-world heart failure population: data from the Swedish heart failure registry
Doctor T. Thorvaldsen (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Metformin reduces myocardial oxygen consumption and improves myocardial efficiency in pre-diabetic heart failure patients
Doctor A. Larsen (Herning, DK)
Abstract Slides Video
Presentation thumbnail
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in heart failure patients with mid-range and preserved ejection fraction and clinical outcomes: from the KCHF Registry
Doctor Y. Yoshikawa (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
The role of candesartan or carvedilol for prevention of anthracycline induced subclinical cardiotoxicity in breast cancer patients.
Doctor M. Lee (Daejeon, KR)
Abstract

Access the full session

Session thumbnail
Rapid Fire 4 - Chronic heart failure - Pharmacology

The Event

Event poster

Heart Failure 2019

27 May 2019 08:48 CET
You may be interested in
thumbnail
Congress Presentation
Incremental efficacy of medical therapy for chronic heart failure with a reduced ejection fraction: a systematic review and network meta-analysis
1 July 2021
thumbnail
Congress Presentation
Optimizing beta-blocker therapy in acute heart failure: insights from a nationwide registry
30 August 2025
thumbnail
Webinar
Are beta-blockers still indicated after myocardial infarction?
17 November 2025
thumbnail
Congress Presentation
Target dose of heart failure medications is associated with better mortality/morbidity: data from the Swedish Heart Failure Registry
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources